Literature DB >> 2784359

Reduced numbers of calcitonin gene-related peptide-(CGRP-) and tachykinin-immunoreactive sensory neurones associated with greater enkephalin immunoreactivity in the dorsal horn of a mutant rat with hereditary sensory neuropathy.

S Kar1, S J Gibson, F Scaravilli, J M Jacobs, V R Aber, J M Polak.   

Abstract

The mutilated foot rat is a mutant with autosomal recessive sensory neuropathy and frequent mutilation of the hindlimbs. Decreased numbers of dorsal root ganglion cells and diminished sensitivity to painful stimuli are characteristics of these animals. By use of immunocytochemistry, changes in the distributions of peptides involved in sensory and/or autonomic regulation, i.e., calcitonin gene-related peptide (CGRP), tachykinins, enkephalin and neuropeptide Y in spinal cord, dorsal root ganglia and skin of these animals, were studied. In comparison with normal litter-mate controls, the dorsal horn of mutilated foot rats contained substantially fewer CGRP- and tachykinin-immunoreactive fibres but more fibres immunoreactive for enkephalin. Many enkephalin-immunoreactive cell bodies were also found in the dorsal horn of the mutants, by contrast none were visible in control animals. Neuropeptide Y immunoreactivity was, however, unchanged in the spinal cord of the mutants. In the dorsal root ganglia of the mutants, the number of CGRP- or tachykinin-immunoreactive cells and their proportion to total neuronal numbers were significantly less in comparison with normal controls. The diameter range of CGRP- and tachykinin-immunoreactive cells shifted from small (15-25 microns) to medium size (25-45 microns) as revealed by frequency distribution histograms. The skin from the affected fore- and hindlimbs of the mutant rats, in keeping with fewer CGRP- and tachykinin-immunoreactive cells in the dorsal root ganglia, contained substantially less fibres immunoreactive for CGRP and tachykinins; a difference that was not seen in skin of unaffected areas (whiskers and snout). By contrast, neuropeptide Y-immunoreactive fibres showed a normal distribution around blood vessels and sweat glands of mutilated foot rats. The data suggest that diminished pain perception in the mutilated foot rat is related to loss of peptide-containing sensory neurones. Furthermore, the intraspinal increase of enkephalinergic neurons in the dorsal horn, concomitant with the decreased number of primary sensory neurones, may also play a contributory rôle in reducing pain thresholds.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784359     DOI: 10.1007/bf00224131

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  64 in total

1.  Neuropeptide Y: A putative neurotransmitter.

Authors:  C Maccarrone; B Jarrott
Journal:  Neurochem Int       Date:  1986       Impact factor: 3.921

2.  Substance p: localization in the central nervous system and in some primary sensory neurons.

Authors:  T Hökfelt; J O Kellerth; G Nilsson; B Pernow
Journal:  Science       Date:  1975-11-28       Impact factor: 47.728

Review 3.  Multiple opioid systems and pain.

Authors:  M J Millan
Journal:  Pain       Date:  1986-12       Impact factor: 6.961

4.  Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P.

Authors:  T Hökfelt; A Ljungdahl; L Terenius; R Elde; G Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

5.  Immunohistochemical studies on the effect of capsaicin on spinal and medullary peptide and monoamine neurons using antisera to substance P, gastrin/CCK, somatostatin, VIP, enkephalin, neurotensin and 5-hydroxytryptamine.

Authors:  G Jancsó; T Hökfelt; J M Lundberg; E Kiraly; N Halász; G Nilsson; L Terenius; J Rehfeld; H Steinbusch; A Verhofstad; R Elde; S Said; M Brown
Journal:  J Neurocytol       Date:  1981-12

6.  Calcitonin gene-related peptide messenger RNA is expressed in sensory neurones of the dorsal root ganglia and also in spinal motoneurones in man and rat.

Authors:  S J Gibson; J M Polak; A Giaid; Q A Hamid; S Kar; P M Jones; P Denny; S Legon; S G Amara; R K Craig
Journal:  Neurosci Lett       Date:  1988-09-12       Impact factor: 3.046

7.  Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide.

Authors:  R Gamse; A Saria
Journal:  Eur J Pharmacol       Date:  1985-08-07       Impact factor: 4.432

8.  The effect of sympathectomy on calcitonin gene-related peptide levels in the rat trigeminovascular system.

Authors:  F Schon; M Ghatei; J M Allen; P K Mulderry; J S Kelly; S R Bloom
Journal:  Brain Res       Date:  1985-11-25       Impact factor: 3.252

Review 9.  Neuropeptides in pelvic afferent pathways.

Authors:  W C de Groat
Journal:  Experientia       Date:  1987-07-15

10.  Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells.

Authors:  G Ju; T Hökfelt; E Brodin; J Fahrenkrug; J A Fischer; P Frey; R P Elde; J C Brown
Journal:  Cell Tissue Res       Date:  1987-02       Impact factor: 5.249

View more
  3 in total

1.  Increased calcitonin gene-related peptide (CGRP), substance P, and enkephalin immunoreactivities in dorsal spinal cord and loss of CGRP-immunoreactive motoneurons in arthritic rats depend on intact peripheral nerve supply.

Authors:  S Kar; S J Gibson; R G Rees; W G Jura; D A Brewerton; J M Polak
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

2.  Changes in sensory neuropeptides in dorsal root ganglion and spinal cord of spontaneously diabetic BB rats. A quantitative immunohistochemical study.

Authors:  G Terenghi; S Chen; A L Carrington; J M Polak; D R Tomlinson
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280

3.  Bone adaptation to mechanical loading in a mouse model of reduced peripheral sensory nerve function.

Authors:  Mollie A Heffner; Damian C Genetos; Blaine A Christiansen
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.